These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26531701)

  • 1. Peripheral blood non-MAIT CD8+CD161hi cells are decreased in relapsing-remitting multiple sclerosis patients treated with interferon beta.
    Negrotto L; Cantó E; Río J; Tintoré M; Montalban X; Comabella M
    J Neuroimmunol; 2015 Nov; 288():98-101. PubMed ID: 26531701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta therapy reduces CD4+ and CD8+ T-cell reactivity in multiple sclerosis.
    Zafranskaya M; Oschmann P; Engel R; Weishaupt A; van Noort JM; Jomaa H; Eberl M
    Immunology; 2007 May; 121(1):29-39. PubMed ID: 17239199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8⁺ MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis.
    Willing A; Leach OA; Ufer F; Attfield KE; Steinbach K; Kursawe N; Piedavent M; Friese MA
    Eur J Immunol; 2014 Oct; 44(10):3119-28. PubMed ID: 25043505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8
    Nicol B; Salou M; Vogel I; Garcia A; Dugast E; Morille J; Kilens S; Charpentier E; Donnart A; Nedellec S; Jacq-Foucher M; Le Frère F; Wiertlewski S; Bourreille A; Brouard S; Michel L; David L; Gourraud PA; Degauque N; Nicot AB; Berthelot L; Laplaud DA
    J Autoimmun; 2018 Mar; 88():61-74. PubMed ID: 29054368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking reduces circulating CD26
    Ammitzbøll C; Börnsen L; Romme Christensen J; Ratzer R; Romme Nielsen B; Søndergaard HB; von Essen MR; Sellebjerg F
    J Leukoc Biol; 2017 May; 101(5):1211-1220. PubMed ID: 28179539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNbeta-1a therapy for multiple sclerosis expands regulatory CD8+ T cells and decreases memory CD8+ subset: a longitudinal 1-year study.
    Aristimuño C; de Andrés C; Bartolomé M; de las Heras V; Martínez-Ginés ML; Arroyo R; Fernández-Cruz E; Sánchez-Ramón S
    Clin Immunol; 2010 Feb; 134(2):148-57. PubMed ID: 19900844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis.
    Martínez-Rodríguez JE; López-Botet M; Munteis E; Rio J; Roquer J; Montalban X; Comabella M
    Clin Immunol; 2011 Dec; 141(3):348-56. PubMed ID: 21992960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation.
    Greathead L; Metcalf R; Gazzard B; Gotch F; Steel A; Kelleher P
    AIDS; 2014 Jul; 28(11):1690-2. PubMed ID: 24911351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral loss of CD8(+) CD161(++) TCRVα7·2(+) mucosal-associated invariant T cells in chronic hepatitis C virus-infected patients.
    Barathan M; Mohamed R; Vadivelu J; Chang LY; Saeidi A; Yong YK; Ravishankar Ram M; Gopal K; Velu V; Larsson M; Shankar EM
    Eur J Clin Invest; 2016 Feb; 46(2):170-80. PubMed ID: 26681320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Circulating CD8+ CD161
    Acquaviva M; Bassani C; Sarno N; Dalla Costa G; Romeo M; Sangalli F; Colombo B; Moiola L; Martinelli V; Comi G; Farina C
    Front Immunol; 2019; 10():1922. PubMed ID: 31474991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural killer receptors distribution in multiple sclerosis: Relation to clinical course and interferon-beta therapy.
    Martínez-Rodríguez JE; Saez-Borderías A; Munteis E; Romo N; Roquer J; López-Botet M
    Clin Immunol; 2010 Oct; 137(1):41-50. PubMed ID: 20580616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis.
    Miyazaki Y; Miyake S; Chiba A; Lantz O; Yamamura T
    Int Immunol; 2011 Sep; 23(9):529-35. PubMed ID: 21712423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T cell activation correlates with disease activity in clinically isolated syndromes and is regulated by interferon-beta treatment.
    Jensen J; Langkilde AR; Frederiksen JL; Sellebjerg F
    J Neuroimmunol; 2006 Oct; 179(1-2):163-72. PubMed ID: 16919783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The possible role of CD8+/Vα7.2+/CD161++ T (MAIT) and CD8+/Vα7.2+/CD161
    Meggyes M; Szanto J; Lajko A; Farkas B; Varnagy A; Tamas P; Hantosi E; Miko E; Szereday L
    Am J Reprod Immunol; 2018 Feb; 79(2):. PubMed ID: 29265516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MAIT cells in multiple sclerosis and amyotrophic lateral sclerosis.
    De Federicis D; Bassani C; Chiarelli RR; Montini F; Giordano A; Esposito F; Riva N; Quattrini A; Martinelli V; Filippi M; Farina C
    Front Immunol; 2024; 15():1436717. PubMed ID: 39108272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
    Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
    Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fraction of IL-10+ and IL-17+ CD8 T cells is increased in MS patients in remission and during a relapse, but is not influenced by immune modulators.
    Peelen E; Thewissen M; Knippenberg S; Smolders J; Muris AH; Menheere P; Tervaert JW; Hupperts R; Damoiseaux J
    J Neuroimmunol; 2013 May; 258(1-2):77-84. PubMed ID: 23517930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.
    Cosgrove C; Ussher JE; Rauch A; Gärtner K; Kurioka A; Hühn MH; Adelmann K; Kang YH; Fergusson JR; Simmonds P; Goulder P; Hansen TH; Fox J; Günthard HF; Khanna N; Powrie F; Steel A; Gazzard B; Phillips RE; Frater J; Uhlig H; Klenerman P
    Blood; 2013 Feb; 121(6):951-61. PubMed ID: 23255555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyper-Expression of PD-1 Is Associated with the Levels of Exhausted and Dysfunctional Phenotypes of Circulating CD161
    Yong YK; Saeidi A; Tan HY; Rosmawati M; Enström PF; Batran RA; Vasuki V; Chattopadhyay I; Murugesan A; Vignesh R; Kamarulzaman A; Rajarajeswaran J; Ansari AW; Vadivelu J; Ussher JE; Velu V; Larsson M; Shankar EM
    Front Immunol; 2018; 9():472. PubMed ID: 29616020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8(+)Foxp3(+) T cells in peripheral blood of relapsing-remitting multiple sclerosis patients.
    Frisullo G; Nociti V; Iorio R; Plantone D; Patanella AK; Tonali PA; Batocchi AP
    Hum Immunol; 2010 May; 71(5):437-41. PubMed ID: 20138197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.